Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 February 2006

Heart. Published Online First: 10 June 2005. doi:10.1136/hrt.2004.057703
Copyright © 2005 BMJ Publishing Group Ltd & British Cardiovascular Society

Original articles

Favourable long-term prognosis in stable angina pectoris: an extended follow-up of the Angina Prognosis study In Stockholm (APSIS)

Paul Hjemdahl 1*, Sven V Eriksson 2, Claes Held 3, Lennart Forslund 4, Per Näsman 5 and Nina Rehnqvist 6

1 Dept of Medicine, Clin Pharm Unit, Karolinska University Hospital (Solna), Sweden
2 Dept of Internal Medicine, Karolinska Institutet at Danderyd Hospital, Sweden
3 Dept of Medicine, Cardiology Unit, Karolinska University Hospital (Solna), Sweden
4 Medical Products Agency, Uppsala, Sweden
5 Royal Institute of Technology, SE-10044 Stockholm, Sweden
6 Swedish Council on Technology Assessment in Health Care, Stockholm, Sweden

* To whom correspondence should be addressed. E-mail: paul.hjemdahl{at}medks.ki.se.

Accepted 4 May 2005


Abstract

Objective: To evaluate the long term prognosis of patients with stable angina pectoris.

Design: Registry based follow-up (median 9.1 years) of patients participating in the Angina Prognosis Study in Stockholm (APSIS), which was a double-blind, single centre trial of antianginal drug treatment.

Patients: 809 patients (31% women) with stable angina pectoris <70 (59±7 years at inclusion), and an age- and sex-matched reference population from the same catchment area.

Interventions: Double-blind treatment with metoprolol or verapamil during 3.4 years (median), followed by referral for usual care with open treatment.

Main outcome measures: CV death and non-fatal myocardial infarction (MI) in the APSIS cohort, and total mortality in comparisons with reference subjects.

Results: 123 patients died (41 MI, 36 other CV causes), and 72 suffered non-fatal MI. Mortality (19% vs. 6%; p<0.001) and fatal MI (6.6 vs. 1.6%; p<0.001) were increased among male compared to female patients. Diabetes, previous MI, hypertension, and male sex independently predicted CV mortality (p<0.001). Diabetes markedly increased the risk in a small subgruoup of female patients. Male patients hade higher mortality rates than males in the reference population during the first three years (cumulative absolute difference 3.8%), but apparently not thereafter. Female patients had similar mortality rates as females in the reference population throughout the 9.1 years of observation.

Conclusions: Female patients with stable angina had similar mortality rates as matched female reference subjects, but male patients had an increased risk. Diabetes, previous MI, hypertension and male sex were strong risk factors for CV death or MI.

Keywords: death, diabetes mellitus, gender, myocardial infarction, stable angina pectoris


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Tardif, J.-C., Ponikowski, P., Kahan, T., for the ASSOCIATE study Investigators, (2009). Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial. Eur Heart J 30: 540-548 [Abstract] [Full Text]  
  • Norhammar, A, Stenestrand, U, Lindback, J, Wallentin, L, on behalf of the Register of Information and Knowl, (2008). Women younger than 65 years with diabetes mellitus are a high-risk group after myocardial infarction: a report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA). Heart 94: 1565-1570 [Abstract] [Full Text]  
  • Meier, P., Gloekler, S., Zbinden, R., Beckh, S., de Marchi, S. F., Zbinden, S., Wustmann, K., Billinger, M., Vogel, R., Cook, S., Wenaweser, P., Togni, M., Windecker, S., Meier, B., Seiler, C. (2007). Beneficial Effect of Recruitable Collaterals: A 10-Year Follow-Up Study in Patients With Stable Coronary Artery Disease Undergoing Quantitative Collateral Measurements. Circulation 116: 975-983 [Abstract] [Full Text]  
  • Poole-Wilson, P. A., Voko, Z., Kirwan, B.-A., de Brouwer, S., Dunselman, P. H.J.M., Lubsen, J., for the ACTION investigators, (2007). Clinical course of isolated stable angina due to coronary heart disease. Eur Heart J 28: 1928-1935 [Abstract] [Full Text]  
  • Sutton, G. C., Otterstad, J. E., Kirwan, B.-A., Voko, Z., de Brouwer, S., Lubsen, J., Poole-Wilson, P. A., ACTION (A Coronary disease Trial Investigating Out, (2007). The development of heart failure in patients with stable angina pectoris. Eur J Heart Fail 9: 234-242 [Abstract] [Full Text]  
  • Jones, M., Rait, G., Falconer, J., Feder, G. (2006). Systematic review: prognosis of angina in primary care. Fam Pract 23: 520-528 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.